Transaction · 0001127602-25-002030

Telman Deborah H

Telman Deborah H, EVP, CA, GC, reported a transaction classified as exercise at GILEAD SCIENCES, INC. involving 515.000000 shares. Reported holdings after the transaction were 27879.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, CA, GC
GILDGILEAD SCIENCES, INC.
Filing timeJan 27
Trade dateJan 25, 2025
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

GILD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
GILD since 2025-01-27Filed 608 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001127602-25-002030
Restricted Stock Unit
Transaction date
Jan 25, 2025
Filed Jan 27, 2025, 10:47 PM · 2d delay
Shares
515 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
27.8k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership
-14score
Filing-only score

-14

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Corporate Affairs & GC

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

  2. F2

    The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Original filing · 0001127602-25-002030
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

GILD